Literature DB >> 27225765

Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Shayla E Russell1, Daniel J Puttick1, Allison M Sawyer1, David N Potter1, Stephen Mague1, William A Carlezon1, Elena H Chartoff2.   

Abstract

UNLABELLED: Dependence is a hallmark feature of opiate addiction and is defined by the emergence of somatic and affective withdrawal signs. The nucleus accumbens (NAc) integrates dopaminergic and glutamatergic inputs to mediate rewarding and aversive properties of opiates. Evidence suggests that AMPA glutamate-receptor-dependent synaptic plasticity within the NAc underlies aspects of addiction. However, the degree to which NAc AMPA receptors (AMPARs) contribute to somatic and affective signs of opiate withdrawal is not fully understood. Here, we show that microinjection of the AMPAR antagonist NBQX into the NAc shell of morphine-dependent rats prevented naloxone-induced conditioned place aversions and decreases in sensitivity to brain stimulation reward, but had no effect on somatic withdrawal signs. Using a protein cross-linking approach, we found that the surface/intracellular ratio of NAc GluA1, but not GluA2, increased with morphine treatment, suggesting postsynaptic insertion of GluA2-lacking AMPARs. Consistent with this, 1-naphthylacetyl spermine trihydrochloride (NASPM), an antagonist of GluA2-lacking AMPARs, attenuated naloxone-induced decreases in sensitivity to brain stimulation reward. Naloxone decreased the surface/intracellular ratio and synaptosomal membrane levels of NAc GluA1 in morphine-dependent rats, suggesting a compensatory removal of AMPARs from synaptic zones. Together, these findings indicate that chronic morphine increases synaptic availability of GluA1-containing AMPARs in the NAc, which is necessary for triggering negative-affective states in response to naloxone. This is broadly consistent with the hypothesis that activation of NAc neurons produces acute aversive states and raises the possibility that inhibiting AMPA transmission selectively in the NAc may have therapeutic value in the treatment of addiction. SIGNIFICANCE STATEMENT: Morphine dependence and withdrawal result in profound negative-affective states that play a major role in the maintenance of addiction. However, the underlying neurobiological mechanisms are not fully understood. We use a rat model of morphine dependence to show that GluA1 subunits of AMPA glutamate receptors in the nucleus accumbens (NAc), a brain region critical for modulating affective states, are necessary for aversive effects of morphine withdrawal. Using biochemical methods in NAc tissue, we show that morphine dependence increases cell surface expression of GluA1, suggesting that neurons in this area are primed for increased AMPA receptor activation upon withdrawal. This work is important because it suggests that targeting AMPA receptor trafficking and activation could provide novel targets for addiction treatment.
Copyright © 2016 the authors 0270-6474/16/365748-15$15.00/0.

Entities:  

Keywords:  GluA1; ICSS; glutamate; opiate; place conditioning; withdrawal

Mesh:

Substances:

Year:  2016        PMID: 27225765      PMCID: PMC4879196          DOI: 10.1523/JNEUROSCI.2875-12.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  77 in total

Review 1.  Localization of drug reward mechanisms by intracranial injections.

Authors:  R A Wise; D C Hoffman
Journal:  Synapse       Date:  1992-03       Impact factor: 2.562

2.  A protein cross-linking assay for measuring cell surface expression of glutamate receptor subunits in the rodent brain after in vivo treatments.

Authors:  Amy C Boudreau; Mike Milovanovic; Kelly L Conrad; Christopher Nelson; Carrie R Ferrario; Marina E Wolf
Journal:  Curr Protoc Neurosci       Date:  2012-04

3.  Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

Authors:  A W Dunah; D G Standaert
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

4.  Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input.

Authors:  P O'Donnell; A A Grace
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

5.  Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.

Authors:  Elena H Chartoff; Carrie L Heusner; Richard D Palmiter
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

6.  Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward.

Authors:  W A Carlezon; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1996-12       Impact factor: 4.530

Review 7.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

8.  NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice.

Authors:  J M Goldstein; L C Litwin
Journal:  Mol Chem Neuropathol       Date:  1993 Jan-Feb

9.  The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

Authors:  Hilarie C Tomasiewicz; Mark S Todtenkopf; Elena H Chartoff; Bruce M Cohen; William A Carlezon
Journal:  Biol Psychiatry       Date:  2008-07-17       Impact factor: 13.382

10.  Nucleus accumbens neurons exhibit synaptic scaling that is occluded by repeated dopamine pre-exposure.

Authors:  Xiu Sun; Marina E Wolf
Journal:  Eur J Neurosci       Date:  2009-08-07       Impact factor: 3.386

View more
  18 in total

Review 1.  Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

Authors:  George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2017-01-03       Impact factor: 4.530

Review 2.  Prefrontal-accumbens opioid plasticity: Implications for relapse and dependence.

Authors:  Matthew Hearing
Journal:  Pharmacol Res       Date:  2018-11-19       Impact factor: 7.658

3.  Ethanol Experience Enhances Glutamatergic Ventral Hippocampal Inputs to D1 Receptor-Expressing Medium Spiny Neurons in the Nucleus Accumbens Shell.

Authors:  Daniel M Kircher; Heather C Aziz; Regina A Mangieri; Richard A Morrisett
Journal:  J Neurosci       Date:  2019-01-28       Impact factor: 6.167

4.  Role of AMPA receptors in homocysteine-NMDA receptor-induced crosstalk between ERK and p38 MAPK.

Authors:  Ranjana Poddar; Alexandria Chen; Lucas Winter; Sathyanarayanan Rajagopal; Surojit Paul
Journal:  J Neurochem       Date:  2017-06-29       Impact factor: 5.372

Review 5.  Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation.

Authors:  Catherine M Cahill; Wendy Walwyn; Anna M W Taylor; Amynah A A Pradhan; Christopher J Evans
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

Review 6.  Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling.

Authors:  Matthew Hearing; Nicholas Graziane; Yan Dong; Mark J Thomas
Journal:  Trends Pharmacol Sci       Date:  2018-01-12       Impact factor: 14.819

Review 7.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

Review 8.  Opioid-induced structural and functional plasticity of medium-spiny neurons in the nucleus accumbens.

Authors:  Benjamin L Thompson; Marlene Oscar-Berman; Gary B Kaplan
Journal:  Neurosci Biobehav Rev       Date:  2020-11-02       Impact factor: 8.989

Review 9.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

10.  Early life adversity promotes resilience to opioid addiction-related phenotypes in male rats and sex-specific transcriptional changes.

Authors:  Evelyn Ordoñes Sanchez; Charlotte C Bavley; Andre U Deutschmann; Rachel Carpenter; Drew R Peterson; Reza Karbalaei; James Flowers; Charleanne M Rogers; Miranda G Langrehr; Cory S Ardekani; Sydney T Famularo; Angela R Bongiovanni; Melissa C Knouse; Stan B Floresco; Lisa A Briand; Mathieu E Wimmer; Debra A Bangasser
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.